7Baggers
 (gh) as a liquidity pulse for institutional tactics  news.stocktradersdaily.com Mon, 17 Nov 2025 14:34:02 GMT
 noninvasive cancer diagnostics and technologies market set  openPR.com Mon, 17 Nov 2025 07:37:36 GMT
 Don't Ignore The Insider Selling In Guardant Health  simplywall.st Wed, 12 Nov 2025 18:51:14 GMT
 insider sell: john saia sells shares of guardant health inc (gh)  GuruFocus Tue, 11 Nov 2025 02:13:55 GMT
 Guardant Health director Hidalgo Medina sells $142k in stock  Investing.com Tue, 11 Nov 2025 00:32:18 GMT
 Saia, Guardant Health chief legal officer, sells $865k in stock  Investing.com Tue, 11 Nov 2025 00:32:18 GMT
 Guardant Health expands blood test to monitor cancer therapy response  Investing.com Mon, 10 Nov 2025 13:26:00 GMT
 radnet earnings: what to look for from rdnt  TradingView Sat, 08 Nov 2025 03:00:00 GMT
 Guardant Health to Participate in Upcoming Investor Conferences  Business Wire Fri, 07 Nov 2025 13:00:00 GMT
 guardant health completes $402.5m convertible notes offering  TipRanks Fri, 07 Nov 2025 08:00:00 GMT
 (gh) risk channels and responsive allocation  news.stocktradersdaily.com Thu, 06 Nov 2025 13:24:03 GMT
 guardant health prices upsized $300 million common stock offering by investing.com  Investing.com Nigeria Thu, 06 Nov 2025 05:10:23 GMT
 guardant health (gh) blood test shows high adherence for colorec  GuruFocus Wed, 05 Nov 2025 22:31:43 GMT
 guardant health launches $250 million common stock offering by investing.com  Investing.com Australia Wed, 05 Nov 2025 21:35:00 GMT
 guardant health reaches new 52-week high of $95.88, up 207%  Markets Mojo Wed, 05 Nov 2025 19:16:36 GMT
 gh: key insights on recent underwriting developments  GuruFocus Wed, 05 Nov 2025 11:10:06 GMT
 guardant health prices upsized offering at $90 per share  MarketScreener Wed, 05 Nov 2025 08:56:53 GMT
 Guardant Health prices upsized $300 million common stock offering  Investing.com Wed, 05 Nov 2025 08:00:00 GMT
 Guardant Health prices upsized $350 million convertible notes offering  Investing.com Wed, 05 Nov 2025 08:00:00 GMT
 why guardant health (gh) shares are sliding today  Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
 guardant health: shield shows 95 percent adherence in cancer screening  Traders Union Wed, 05 Nov 2025 07:15:25 GMT
 the top 5 analyst questions from guardant health’s q3 earnings call  Markets Financial Content Wed, 05 Nov 2025 05:37:00 GMT
 guardant health stock price target raised to $115 from $61 at raymond james  Investing.com India Wed, 05 Nov 2025 00:18:09 GMT
 guardant health announces $250m common stock offering  TipRanks Tue, 04 Nov 2025 23:40:05 GMT
 guardant health (gh) plans $300m convertible notes offering  GuruFocus Tue, 04 Nov 2025 22:44:57 GMT
 guardant health stock soars on strong q3 results  TipRanks Tue, 04 Nov 2025 22:10:32 GMT
 guardant health plans to offer $300 million in convertible notes  Investing.com Tue, 04 Nov 2025 21:49:33 GMT
 guardant health (nasdaq:gh) reaches new 1-year high - what's next?  MarketBeat Tue, 04 Nov 2025 17:13:51 GMT
 guardant health stock hits 52-week high at 95.99 usd by investing.com  Investing.com Australia Tue, 04 Nov 2025 13:51:58 GMT
 oncology blood testing market growth analysis | cagr of 15.2%  Market.us Tue, 04 Nov 2025 11:56:24 GMT
 Guardant Health Announces Proposed Public Offering of Common Stock  Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
 The Top 5 Analyst Questions From Guardant Health’s Q3 Earnings Call  Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
 Guardant Health launches $250 million common stock offering  Investing.com Tue, 04 Nov 2025 08:00:00 GMT
 guardant health shares surge on strong q3 results  TipRanks Mon, 03 Nov 2025 20:28:53 GMT
 guardant health price target raised to $100 from $70 at stifel  TipRanks Mon, 03 Nov 2025 15:20:12 GMT
 united states esr1 mutated metastatic breast cancer  openPR.com Mon, 03 Nov 2025 11:57:00 GMT

Guardant Health
(NASDAQ:GH) 

GH stock logo

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico resear...

Founded: 2013
IPO Price: $19 (Oct 04, 2018)
Full Time Employees: 1,728 (Dec 2022)
CEO / Co-Founder: Helmy Eltoukhy 
Sector: Healthcare
Industry: Diagnostics & Research
blind

Share this website to your friends